Paper26729
Large-scale production of human leukocyte interferon containing 10(8) units per ml.
Cantell K and 1 other. J Gen Virol, 1978. Cited by 242 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Large-scale production of human leukocyte interferon containing 10(8) units per ml. Papers, record 26729. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26729
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Leukocytes | Major topic |
| Chemical Precipitation | |
| Ethanol | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Serum Albumin | |
| Solvents | |
| Thiocyanates |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 242 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,648,466 | Cloning of human Type I interferon cDNAs. | Proc Jpn Acad Ser B Phys Biol Sci | 2024 | https://conductscience.org/library/papers/37648466 | PubMed |
| 32,288,182 | Biological and antigenic relationships between virus-induced porcine and human interferons. | Ann Inst Pasteur Virol | 1986 | https://conductscience.org/library/papers/32288182 | PubMed |
| 6,559,104 | Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6559104 | PubMed |
| 6,477,131 | Purification of human leukocyte interferon alpha by carboxymethyl controlled pore glass bead chromatography. | Arch Virol | 1984 | https://conductscience.org/library/papers/6477131 | PubMed |
| 6,400,035 | Studies with interferon-alpha in human tumors. | Med Oncol Tumor Pharmacother | 1984 | https://conductscience.org/library/papers/6400035 | PubMed |
| 6,365,781 | Functions of human neutrophilic granulocytes after in vivo exposure to interferon alpha. | Infect Immun | 1984 | https://conductscience.org/library/papers/6365781 | PubMed |
| 6,361,069 | Interferon enhances prostacyclin production by cultured vascular endothelial cells. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6361069 | PubMed |
| 6,301,405 | Characteristics of spontaneously produced and of virus-induced human LuKII cell interferons. | Arch Virol | 1983 | https://conductscience.org/library/papers/6301405 | PubMed |
| 6,299,206 | Natural killer cell activity in atopic dermatitis. | Arch Dermatol Res | 1982 | https://conductscience.org/library/papers/6299206 | PubMed |
| 6,243,919 | Human leukocyte interferon: separation of biologically different species by modification of carbohydrate moieties. | Arch Virol | 1980 | https://conductscience.org/library/papers/6243919 | PubMed |
| 6,180,853 | Natural killer cell function of human neonatal lymphocytes. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6180853 | PubMed |
| 6,177,374 | Purified interferon as protection against rhinovirus infection. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6177374 | PubMed |
| 6,174,194 | Interferon: no verdict yet. | Can Med Assoc J | 1982 | https://conductscience.org/library/papers/6174194 | PubMed |
| 6,170,256 | Combined protective effects on interferon and interferon induction on herpes simplex and ectromelia virus infections in mice. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6170256 | PubMed |
| 6,167,863 | Comparative antiviral efficiency of leukocyte and bacterially produced human alpha-interferon in rhesus monkeys. | Nature | 1981 | https://conductscience.org/library/papers/6167863 | PubMed |
| 6,165,986 | Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6165986 | PubMed |
| 6,165,428 | Toxicity of interferon. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6165428 | PubMed |
| 6,160,588 | Spontaneous production of human interferon. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6160588 | PubMed |
| 4,077,098 | Effect of interferon on chemiluminescence and hydroxyl radical production in murine macrophages stimulated by PMA. | Immunology | 1985 | https://conductscience.org/library/papers/4077098 | PubMed |
| 3,936,656 | Interferon induces proliferation and differentiation in primary chronic lymphocytic leukaemia cells. | Clin Exp Immunol | 1985 | https://conductscience.org/library/papers/3936656 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26729
GET https://conductscience.org/api/papers/v1/26729/cited_by?page=2